Patricia Lynn Russek, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6798 Crosswinds Drive North, Stuite B102, St Petersburg, FL 33710 Phone: 727-381-9400 Fax: 727-381-9181 |
Ronald James Gabriau, SW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3050 1st Ave S, St Petersburg, FL 33712 Phone: 727-735-7421 |
Stephanie Abigail Adams Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3601 18th St N, St Petersburg, FL 33713 Phone: 181-827-6546 |
Katherine Planchard, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9400 4th St N Ste 200, St Petersburg, FL 33702 Phone: 717-608-0329 |
Victoria Anne Silvers, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3840 5th Ave N, St Petersburg, FL 33713 Phone: 727-367-2273 |
Rahim Samji, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3010 Fairfield Ave S, St Petersburg, FL 33712 Phone: 727-265-1598 |
Patricia Lomando, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7901 4th St N Ste 13636, St Petersburg, FL 33702 Phone: 786-401-5603 |
Kimberly Ann Wagner-rohrs, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 3082 Granville Ct N, St Petersburg, FL 33704 Phone: 727-251-0280 |
News Archive
People with disabilities have crucial healthcare needs, but often experience difficulty in receiving much-needed treatment, according to Allsup, a nationwide provider of Social Security disability representation and Medicare services.
News outlets report on efforts to implement the new health law, including high risk pools and insurers' summaries of their plans.
"For the poor, cancer remains a silent killer. Breaking this silence could save hundreds of thousands and likely even millions of lives each year - most of them in developing, low- and middle-income countries (LMICs)," Felicia Knaul, secretariat co-director of the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, writes in the Huffington Post's "World" blog.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that canagliflozin, an investigational, oral, selective sodium-glucose transporter-2 inhibitor, improved glycemic control, and was also associated with a decrease in body weight, in a Phase 2b dose-ranging trial in patients diagnosed with type 2 diabetes who were concurrently treated with metformin. The data were presented at the 70th American Diabetes Association Scientific Sessions.
A group in the Department of Immunology, Microbiology and Parasitology at the UPV/EHU has conducted an in-depth study into the capacity to survive of the Acinetobacter baumannii bacterium as well as the strategies it uses to survive.
› Verified 1 days ago